Leerink Partners analyst Michael Cherny has maintained their bullish stance on IQV stock, giving a Buy rating yesterday.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Michael Cherny has given his Buy rating due to a combination of factors that suggest stability and growth for IQVIA Holdings. The transition of the CFO role from Ron Bruehlman to Michael Fedock is expected to be smooth, as Fedock is an internal candidate with extensive experience in the company. This seamless transition is anticipated to support the company’s ongoing growth strategies, including core growth, inorganic investments, and margin expansion efforts.
Additionally, Cherny believes that the current market valuation of IQVIA Holdings does not fully reflect the improvements in the biopharma R&D environment, which has shown signs of stability and growth this year. The company’s stable performance in its Technology & Analytics Solutions (TAS) segment further supports this positive outlook. As a result, Cherny maintains a positive view on IQVIA Holdings, reinforcing his Buy rating.